美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      New hires:

      Acadia Pharmaceuticals named Allyson McMillan-Youngblood as SVP of the rare disease franchise.

      Indivior appointed Patrick Barry as its chief commercial officer.

      Hillstar Bio appointed former Seismic Therapeutic exec Maude Tessier, PhD as COO.

      MC2 Therapeutics named Trine Ahlgreen as its CEO.

      Evidently named former Twilio exec Andrés Krogh-Walker as head of marketing.

      MindMed named Brandi Roberts as CFO.

      Alyssa Mogavero, MBA was named VP of business development at Healthcasts.

      Glenmark Pharma named Anurag Mantri as its global CFO.

      Life365 named Healthcare Veteran Jay Roberts as chief development officer

      Swiss Rockets AG added three leaders to its executive team.

      Conscience welcomed Peng Fu as CEO.

      BioTech CellCentric appointed Celia Economides as its CFO.

      Executive elevations:

      Australian biotech TekCyte Limited appointed a new co-CEO leadership team consisting of Tony Simula, TekCyte’s founding CEO, as well as Tara James, a commercial strategist and founder of Small and Mighty Group.

      Board appointments:

      TransCode Therapeutics named Dr. Phillip D. Zamore to its science advisory board.

      CDR-Life named Pascal Touchon to its board of directors.

      Immuneonco Biopharmaceuticals announced its board composition.

      Miscellaneous:

      Health and Human Services Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and healthy pregnant people get COVID-19 shots.

      Sen. Dick Durbin, (D-Ill.), sent a letter to Food and Drug Administration Commissioner Marty Makary raising concerns about the agency’s ability to regulate pharmaceutical advertising after layoffs and departures.

      The Department of Justice charged five people – including Rouzbeh “Ross” Haghighat – for allegedly participating in securities fraud in connection with Novartis’ $3.2 billion acquisition of Chinook Therapeutics in June 2023.

      Flow Neuroscience CEO Erin Lee called out the FDA for market entry delays for clinically validated devices for treating depression.

      Takeda Pharmaceutical announced that applications are now open for its Innovators in Science Award.

      GlycoEra announced it has been recruiting clinical development experts as it prepares to launch its first clinical trial later this year.

      Pharmaceutical CEOs alerted European Commission President Ursula von der Leyen about a potential shift in their operational focus toward the U.S.

      See last week’s edition of The Escalator.